Newsletters and Deep Dive digital magazine
What changes will the appointment of Matt Hancock MP as Secretary of State for Health and Social Care mean for the NHS?
As attention shifts to what will replace the 2014 Pharmaceutical Price Regulation Scheme (PPRS), Leela Barham provides the first in a series of five features to look at whether the scheme has m
Leela Barham delves into the Department of Health’s accounts to see how contributions from the updated Pharmaceutical Price Regulation Scheme (PPRS) have affected its budget for the NHS since s
The Department of Health has appointed a former UK head of Sanofi and Teva to be its chief commerci
A continued government squeeze on funding will cause a deterioration in care quality on the National Health Service, a report has warned.
The venture capital arms of MSD and Amgen have provided $10 million in funding to Culmination Bio, a Utah start-up that aims to build the largest disease-agnostic patient
On 1st October, the roll-out of the National Contract Value Review (NCVR) process marked a pivotal moment in the trajectory of clinical research in the UK, introducing a standardised, natio